Decreasing hepatitis B seroprevalence in pregnant women in Taiwan between 2016 and 2021: a claim-based cohort study
The implementation of national vaccination programs has demonstrated significant success in reducing HBV seroprevalence among pregnant women, which is particularly evident in the substantial decrease in HBsAg seroprevalence in Taiwan post-July 1986. These findings emphasize the importance of continued and consistent vaccination efforts, supporting the need for ongoing public health strategies to combat HBV infections effectively.
Authors
- Juan C. Vargas-Zambrano (ORCID: https://orcid.org/0000-0002-5609-7046)
- Li‐Nien Chien (ORCID: https://orcid.org/0000-0001-9441-552X)
- Meng‐Yun Ku
Institutions
- National Yang Ming Chiao Tung University (TW)
- Sanofi (France) (FR)
- Taipei Medical University (TW)
Publication Details
- Journal
- BMC Public Health
- Published
- 2025-01-09
- DOI
- https://doi.org/10.1186/s12889-025-21308-3
- Primary Topic
- Hepatitis B Virus Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Sanofi
- Ministry of Health and Welfare
- National Health Insurance Administration